MYOMICS, INC.

Company Information

Company Name
MYOMICS, INC.
Address
MYOMICS, INC.
148 West River Street
PROVIDENCE, RI, 02904 2615
Phone
n/a
URL
n/a
DUNS
139717537
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$298,039.00
3
SBIR Phase II
$1,491,944.00
2
STTR Phase I
$99,939.00
1
Chart code to be here

Award List

  1. SBIR Phase I: Physiologic High Throughput Screening of Bioengineered Tissues

    Amount: $99,991.00

    The Small Business Innovation Research (SBIR) Phase I project will develop an innovative high-throughput/ high content drug screening platform utilizing three-dimensional human skeletal muscle tissue ...

    SBIR Phase I 2006 National Science Foundation
  2. Electro-Mechanical Micro-Post Array to Detect In Vitro Muscle Contraction

    Amount: $99,939.00

    DESCRIPTION (provided by applicant): Myomics? technology to be developed in this Phase 1 project is based upon an in vitro skeletal muscle tissue force measurement technique for high throughput screen ...

    STTR Phase I 2006 Department of Health and Human Services
  3. High Content Screening for Muscular Dystrophy

    Amount: $99,912.00

    DESCRIPTION (provided by applicant): Myomics' drug screening technology to be developed in this Phase 1 SBIR project for Duchene muscular dystrophy (DMD) is based upon an in vitro skeletal muscle tiss ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. SBIR Phase II: Physiologic High Throughput Screening of Bioengineered Tissues

    Amount: $499,956.00

    This Small Business Innovation Research (SBIR) Phase II research develops an innovative high-throughput/high content drug screening platform that utilizes three-dimensional human skeletal muscle tissu ...

    SBIR Phase II 2007 National Science Foundation
  5. High Content Drug Screening with Cardiac Tissue

    Amount: $98,136.00

    DESCRIPTION (provided by applicant): Myomics, Inc. has developed High Content Drug Screening (HCS) technology for in vitro testing of compounds which alter contractile forces generated by miniaturized ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. High Content Screening for Muscular Dystrophy

    Amount: $991,988.00

    DESCRIPTION (provided by applicant): Duchenne Muscular Dystrophic (DMD) is a fatal genetic disease affecting tens of thousands of boys in the U.S. There is currently no cure for the disease and few d ...

    SBIR Phase II 2009 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government